159 related articles for article (PubMed ID: 20003326)
1. Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma.
Torng PL; Lin CW; Chan MW; Yang HW; Huang SC; Lin CT
Mol Cancer; 2009 Dec; 8():120. PubMed ID: 20003326
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma.
Torng PL; Lee YC; Huang CY; Ye JH; Lin YS; Chu YW; Huang SC; Cohen P; Wu CW; Lin CT
Oncogene; 2008 Apr; 27(15):2137-47. PubMed ID: 17952116
[TBL] [Abstract][Full Text] [Related]
3. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N
BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074
[TBL] [Abstract][Full Text] [Related]
4. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
5. Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer.
Wiley A; Katsaros D; Fracchioli S; Yu H
Int J Gynecol Cancer; 2006; 16(1):210-8. PubMed ID: 16445635
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
[TBL] [Abstract][Full Text] [Related]
7. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinoma.
Kumar A; Singh P; Pandey A; Gosipatala SB
Mol Biol Rep; 2020 Sep; 47(9):6919-6927. PubMed ID: 32929656
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells.
Zeng L; Jarrett C; Brown K; Gillespie KM; Holly JM; Perks CM
Exp Cell Res; 2013 Aug; 319(14):2282-95. PubMed ID: 23810988
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells.
Tsubaki J; Hwa V; Twigg SM; Rosenfeld RG
Endocrinology; 2002 May; 143(5):1778-88. PubMed ID: 11956160
[TBL] [Abstract][Full Text] [Related]
11. Methylation in the p53 promoter in epithelial ovarian cancer.
Chmelarova M; Krepinska E; Spacek J; Laco J; Beranek M; Palicka V
Clin Transl Oncol; 2013 Feb; 15(2):160-3. PubMed ID: 22855178
[TBL] [Abstract][Full Text] [Related]
12. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein-3 gene methylation and protein expression in gastric adenocarcinoma.
Gigek CO; Leal MF; Lisboa LC; Silva PN; Chen ES; Lima EM; Calcagno DQ; Assumpção PP; Burbano RR; Smith Mde A
Growth Horm IGF Res; 2010 Jun; 20(3):234-8. PubMed ID: 20219400
[TBL] [Abstract][Full Text] [Related]
14. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers.
Tomii K; Tsukuda K; Toyooka S; Dote H; Hanafusa T; Asano H; Naitou M; Doihara H; Kisimoto T; Katayama H; Pass HI; Date H; Shimizu N
Int J Cancer; 2007 Feb; 120(3):566-73. PubMed ID: 17096329
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.
Chang YS; Wang L; Suh YA; Mao L; Karpen SJ; Khuri FR; Hong WK; Lee HY
Oncogene; 2004 Aug; 23(39):6569-80. PubMed ID: 15247904
[TBL] [Abstract][Full Text] [Related]
18. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
Ye P; Qu CF; Hu XL
Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
[TBL] [Abstract][Full Text] [Related]
19. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
[TBL] [Abstract][Full Text] [Related]
20. Methylation status of insulin-like growth factor-binding protein 7 concurs with the malignance of oral tongue cancer.
Chen LH; Liu DW; Chang JL; Chen PR; Hsu LP; Lin HY; Chou YF; Lee CF; Yang MC; Wen YH; Hsu WL; Weng CF
J Exp Clin Cancer Res; 2015 Feb; 34(1):20. PubMed ID: 25880247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]